Active — Not RecruitingNot Applicable

Effectiveness and Tolerability of Eqwilate in Real-life Conditions

France38 participantsStarted 2019-11-27

Plain-language summary

MOdalities of use, effectiveNEss and TOlerability of Eqwilate® a balanced combInatiON of VWF and FVIII in von WillEbrand patients in real-life conditions: the ONE-TO-ONE study

Who can participate

Age range6 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: The study will involve patients (≥ 6 years of age) from the participating centres treated with Eqwilate® (either on-demand, as perioperative prophylaxis, or as prophylaxis) during the time inclusion period will be opened. Patients will be of any VWD type, previously treated or untreated. Exclusion Criteria: * N/A

What they're measuring

Haemostatic Effectiveness of On-demand Treatment

Timeframe: 12 months

Haemostatic Effectiveness of Perioperative Prophylaxis

Timeframe: 12 months

Occurrence of Bleeding Episodes During Follow-Up

Timeframe: 12 months

Trial details

NCT IDNCT04106908

SponsorOctapharma

Sponsor typeINDUSTRY

Study typeOBSERVATIONAL

Primary completion2024-05-11

View on ClinicalTrials.gov More VWD - Von Willebrand's Disease trials